Ping An Biomedical CEO Resigns
Ticker: PASW · Form: 6-K · Filed: Oct 14, 2025 · CIK: 1897532
| Field | Detail |
|---|---|
| Company | Ping An Biomedical Co., Ltd. (PASW) |
| Form Type | 6-K |
| Filed Date | Oct 14, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, resignation
TL;DR
Ping An Biomedical CEO Jianhua Li out, no replacement named yet.
AI Summary
Ping An Biomedical Co., Ltd. announced on October 14, 2025, that its Chairman and Chief Executive Officer, Mr. Jianhua Li, has resigned from his positions. The company also stated that Mr. Jianhua Li has resigned from the board of directors. The filing does not specify a replacement for Mr. Li.
Why It Matters
The sudden resignation of a top executive like the CEO can signal internal changes or strategic shifts within the company, potentially impacting its future direction and stock performance.
Risk Assessment
Risk Level: medium — The resignation of a CEO without an immediate replacement creates uncertainty about leadership and future strategy.
Key Players & Entities
- Ping An Biomedical Co., Ltd. (company) — Filing company
- Jianhua Li (person) — Resigning Chairman and CEO
- October 14, 2025 (date) — Date of announcement
FAQ
Who has resigned from Ping An Biomedical Co., Ltd.?
Mr. Jianhua Li has resigned as Chairman and Chief Executive Officer.
What other position did Mr. Jianhua Li hold?
Mr. Jianhua Li also resigned from the board of directors.
When was this resignation announced?
The resignation was announced on October 14, 2025.
Is there a named successor for Mr. Jianhua Li?
The filing does not specify a replacement for Mr. Li.
What is the company's principal executive office location?
The principal executive offices are located at 22/F, China United Plaza, 1002-1008, Tai Nan West Street, Cheung Sha Wan, Kowloon, Hong Kong.
Filing Stats: 626 words · 3 min read · ~2 pages · Grade level 9.9 · Accepted 2025-10-14 06:04:00
Filing Documents
- ea0261043-6k_pingan.htm (6-K) — 13KB
- 0001213900-25-098254.txt ( ) — 15KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PING AN BIOMEDICAL CO., LTD. Date: October 14, 2025 By: /s/ Pijun Liu Name: Pijun Liu Title: Chairman of the Board of Directors 2